Lancet Oncology
Journal Abbreviation: LANCET ONCOL
ISSN: 1470-2045
eISSN: 1474-5488
Publisher: Elsevier: Lancet
Publications (36)
Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial (2015)
Rollig C, Serve H, Huettmann A, Noppeney R, Mueller-Tidow C, Krug U, Baldus CD, et al.
Journal article
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial (2014)
Stupp R, Hegi ME, Gorlia T, Erridge SC, Perry J, Hong YK, Aldape KD, et al.
Journal article
Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial (2014)
Von Minckwitz G, Schneeweiss A, Loibl S, Salat C, Denkert C, Rezai M, Blohmer JU, et al.
Journal article
Surrogate endpoints for overall survival in metastatic melanoma: a meta-analysis of randomised controlled trials (2014)
Flaherty KT, Hennig M, Lee SJ, Ascierto PA, Dummer R, Eggermont AMM, Hauschild A, et al.
Journal article
Chemoradiotherapy for locally advanced pancreatic cancer (2013)
Diener MK, Combs SE, Büchler MW
Journal article
Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial (2012)
Roedel C, Liersch T, Becker H, Fietkau R, Hohenberger W, Hothorn T, Graeven U, et al.
Journal article
